Elsevier

Methods

Volume 95, 15 February 2016, Pages 86-93
Methods

A tale of the epidermal growth factor receptor: The quest for structural resolution on cells

https://doi.org/10.1016/j.ymeth.2015.10.009Get rights and content

Highlights

  • We describe how key concepts in EGFR research have evolved over the preceding decades.

  • Atomic resolution structures provided by X-ray crystallography provide the basis for understanding EGFR.

  • Lower resolution microscopy data from receptors in cell membranes often disagrees.

  • Super-resolution techniques are beginning to bridge the gap between the two.

Abstract

The challenge of determining the architecture and geometry of oligomers of the epidermal growth factor receptor (EGFR) on the cell surface has been approached using a variety of biochemical and biophysical methods. This review is intended to provide a narrative of how key concepts in the field of EGFR research have evolved over the years, from the origins of the prevalent EGFR signalling dimer hypothesis through to the development and implementation of methods that are now challenging the conventional view. The synergy between X-ray crystallography and cellular fluorescence microscopy has become particularly important, precisely because the results from these two methods diverged and highlighted the complexity of the challenge. We illustrate how developments in super-resolution microscopy are now bridging this gap. Exciting times lie ahead where knowledge of the nature of the complexes can assist with the development of a new generation of anti-cancer drugs.

Introduction

The human epidermal growth factor receptor (hEGFR; aka HER1) is the founding member of the growth factor receptor tyrosine kinase (RTK) super-family [1]. This family also comprises 18 sub-groups of cell surface receptors for many growth factors, cytokines and hormones [2]. The evolution of the EGFR family can be traced from one receptor/ligand pair in C. elegans, through one receptor with multiple ligands in D. melanogaster, to a family comprising four receptors (HER1 and ErbB2-4, known as HER2-4 in humans) and at least 13 ligands in mammals [3], [4].

The EGFR family are key regulators of cell-to-cell inductive processes and cell fate [5]. Their function is to transmit growth factor signals from the outside to the inside of the cell where changes in gene expression allow the cell to respond to the new circumstances. Deregulated signalling by cell surface HER1 receptors (e.g. via activating mutations in the HER1 gene) is implicated in a substantial percentage of lung cancers [6]. As activation of these receptors has been shown to result in the growth and progression of the malignancy, there have been considerable research efforts directed toward the development of effective inhibitors of HER1. Several of these cancer drugs are in different stages of pre-clinical and clinical trials [7].

Here we review the efforts towards understanding the structure–function relationships underlying the transduction of the EGF signal and the activation of EGFR across the plasma membrane. This understanding requires the determination of structure at high resolution. Because biological function usually requires the interaction of many molecules within a complex system, a full understanding of the structure–function relationship is only possible if we are able to obtain structural detail of molecules within the context of their natural environment; the cell. Although this inevitably leads us to discussions of how fluorescence based microscopy techniques have been used for this purpose, we have restricted the scope of this review to efforts to elucidate EGFR macromolecular structure. For an excellent review that discusses the imaging of other aspects of EGFR biology such as interaction dynamics and the events subsequent to receptor activation please see [8]. Ultimately the goal would be to obtain atomic resolution structures from molecules in living cells, in real time, but this is likely to remain out of reach for the foreseeable future.

Section snippets

A brief history of 50+ years of EGFR biology

EGFR research can be traced back to the early 1960s, when Stanley Cohen purified the epidermal growth factor (EGF) from mouse submaxillary glands and showed that it induced precocious eyelid opening and tooth eruption in mouse embryos [9]. Given that fibroblast cells in culture responded to a treatment with 125I-labelled EGF by enhancing DNA synthesis and proliferation, Cohen and co-workers began to ask questions about how EGF induces cell growth. Initial experiments showed that EGF

Mapping the size, distribution of EGFR clusters at higher resolution

Whilst the combination of fluorescence imaging and FRET made important contributions towards our understanding of EGFR structure–function relationship, Section 3.3 illustrated that there are multiple ways to construct models of higher order oligomers from known EGFR structures that agree with the available FRET data. It is also worth noting that the expected size of EGFR oligomers (dimers >11 nm and <15 nm, tetramers >20 nm and <30 nm, etc) sits neatly in the gap between FRET which reports short

Conclusions

After nearly 5 decades of research, super-resolution fluorescence microscopy, informed by high resolution structures derived from NMR and X-ray crystallography and combined with the exploratory power of atomistic Molecular Dynamics simulations promises to deliver a deep understanding of EGFR signalling complexes in the environment of the cell membrane. As a target for anti-cancer therapies this will undoubtedly benefit our understanding of these interventions. New insights into the regulation

Acknowledgements

The authors have been funded by the Biotechnology and Biological Sciences Research Council [BB/G006911/1].

References (96)

  • T.P. Garrett et al.

    Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha

    Cell

    (2002)
  • H. Ogiso et al.

    Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains

    Cell

    (2002)
  • A. Arkhipov et al.

    Architecture and membrane interactions of the EGF receptor

    Cell

    (2013)
  • N.F. Endres et al.

    Conformational coupling across the plasma membrane in activation of the EGF receptor

    Cell

    (2013)
  • N. Jura et al.

    Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment

    Cell

    (2009)
  • X. Zhang et al.

    An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor

    Cell

    (2006)
  • E.J. Lowenstein et al.

    The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling

    Cell

    (1992)
  • L. Buday et al.

    Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor

    Cell

    (1993)
  • T. Sasaoka et al.

    The signaling pathway coupling epidermal growth factor receptors to activation of p21ras

    J. Biol. Chem.

    (1994)
  • D. Axelrod et al.

    Mobility measurement by analysis of fluorescence photobleaching recovery kinetics

    Biophys. J.

    (1976)
  • D.C. Gamett et al.

    Secondary dimerization between members of the epidermal growth factor receptor family

    J. Biol. Chem.

    (1997)
  • A.C. King et al.

    Resolution of high and low affinity epidermal growth factor receptors. Inhibition of high affinity component by low temperature, cycloheximide, and phorbol esters

    J. Biol. Chem.

    (1982)
  • E.G. Hofman et al.

    Ligand-induced EGF receptor oligomerization is kinase-dependent and enhances internalization

    J. Biol. Chem.

    (2010)
  • M. Martin-Fernandez et al.

    Preformed oligomeric epidermal growth factor receptors undergo an ectodomain structure change during signaling

    Biophys. J.

    (2002)
  • N.J. Bessman et al.

    Complex relationship between ligand binding and dimerization in the epidermal growth factor receptor

    Cell Rep.

    (2014)
  • D. Alvarado et al.

    Structural basis for negative cooperativity in growth factor binding to an EGF receptor

    Cell

    (2010)
  • A.H. Clayton et al.

    Ligand-induced dimer-tetramer transition during the activation of the cell surface epidermal growth factor receptor-A multidimensional microscopy analysis

    J. Biol. Chem.

    (2005)
  • S.E.D. Webb et al.

    Single-molecule imaging and fluorescence lifetime imaging microscopy show different structures for high- and low-affinity epidermal growth factor receptors in A431 cells

    Biophys. J.

    (2008)
  • J. Kästner et al.

    Ectodomain orientation, conformational plasticity and oligomerization of ErbB1 receptors investigated by molecular dynamics

    J. Struct. Biol.

    (2009)
  • S. Saffarian et al.

    Oligomerization of the EGF receptor investigated by live cell fluorescence intensity distribution analysis

    Biophys. J.

    (2007)
  • M.A. Digman et al.

    Mapping the number of molecules and brightness in the laser scanning microscope

    Biophys. J.

    (2008)
  • L.J. Pike et al.

    Epidermal growth factor receptors are localized to lipid rafts that contain a balance of inner and outer leaflet lipids: a shotgun lipidomics study

    J. Biol. Chem.

    (2005)
  • A. Abulrob et al.

    Nanoscale imaging of epidermal growth factor receptor clustering. Effects of inhibitors

    J. Biol. Chem.

    (2010)
  • H. Balci et al.

    Interhead distance measurements in myosin VI via SHRImP support a simplified hand-over-hand model

    Biophys. J.

    (2005)
  • S.E.D. Webb et al.

    Nanometric molecular separation measurements by single molecule photobleaching

    Methods

    (2015)
  • M.A. Lemmon et al.

    The EGFR family: not so prototypical receptor tyrosine kinases

    Cold Spring Harb. Persp. Biol.

    (2014)
  • Y. Yarden et al.

    Untangling the ErbB signalling network

    Nat. Rev. Mol. Cell Biol.

    (2001)
  • S.L.J. Knudsen et al.

    EGFR signaling patterns are regulated by its different ligands

    Growth Factors

    (2014)
  • J. Downward et al.

    Autophosphorylation sites on the epidermal growth-factor receptor

    Nature

    (1984)
  • J.G. Paez et al.

    EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy

    Science

    (2004)
  • D.M. Jackman et al.

    Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials

    Clin. Cancer Res.

    (2009)
  • C.C. Valley et al.

    The spatiotemporal organization of ErbB receptors: insights from microscopy

    Cold Spring Harb. Persp. Biol.

    (2014)
  • H. Ushiro et al.

    Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes

    J. Biol. Chem.

    (1980)
  • A. Ullrich et al.

    Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

    Nature

    (1984)
  • R. Sever et al.

    Signal transduction in cancer

    Cold Spring Harb. Perspect. Med.

    (2015)
  • T. Hunter et al.

    Protein-tyrosine kinases

    Annu. Rev. Biochem.

    (1985)
  • H.K. Gan et al.

    The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered

    FEBS J.

    (2013)
  • C. Tsatsanis et al.

    Oncogenic kinase signaling in human neoplasms

    Ann. N. Y. Acad. Sci.

    (2004)
  • Cited by (0)

    View full text